Perceptive Advisors’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

Perceptive Advisors’s Portfolio INFI Stock Details INFI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-100,000	Closed	-$527K	–	209
2016 Q1	$527K	Buy	100,000 +80,000	+400%	+$490K	0.05%	115
2015 Q4	$157K	Hold	20,000	–	–	0.01%	142
2015 Q3	$169K	Sell	20,000 -21,000	-51%	-$194K	0.01%	143
2015 Q2	$449K	Sell	41,000 -20,000	-33%	-$257K	0.03%	133
2015 Q1	$853K	Buy	61,000 +45,677	+298%	+$698K	0.07%	108
2014 Q4	$259K	Buy	+15,323	New	+$223K	0.02%	125
2014 Q1	–	Sell	-350,000	Closed	-$4.83M	–	145
2013 Q4	$4.83M	Buy	350,000 +154,845	+79%	+$2.19M	0.58%	39
2013 Q3	$3.4M	Buy	195,155 +83,215	+74%	+$1.59M	0.28%	49
2013 Q2	$1.81M	Buy	+111,940	New	+$3.46M	0.18%	50

Other funds holding INFI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Pinnacle Associates New York $9.16B AUM 63.5% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Perceptive Advisors's INFI Position: Q2 2016 in Review

Perceptive Advisors sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q2 2016, closing a stake of 100,000 shares — an estimated $527K sold.

Perceptive Advisors first reported a position in INFI in Q2 2013 and held it in 9 quarters. The position peaked at $4.83M in Q4 2013. 107 funds tracked by Wall St. Rank hold INFI as of Q2 2016.

Perceptive Advisors reported no remaining Infinity Pharmaceuticals, Inc. position as of Q2 2016 after selling out during the quarter.
Perceptive Advisors sold 100,000 Infinity Pharmaceuticals, Inc. shares in Q2 2016, an estimated $527K.
Perceptive Advisors first reported a position in Infinity Pharmaceuticals, Inc. in Q2 2013 and held it in 9 quarters.
Perceptive Advisors's Infinity Pharmaceuticals, Inc. position peaked at $4.83M in Q4 2013.
107 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q2 2016.

Based on Perceptive Advisors's 13F filing for Q2 2016, filed 11 Aug 2016.